middle.news
Can OncoSil’s $8.7M Raise and Share Consolidation Reset Its Biotech Prospects?
1:41am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Can OncoSil’s $8.7M Raise and Share Consolidation Reset Its Biotech Prospects?
1:41am on Monday 2nd of June, 2025 AEST
Key Points
Proposed $8.7 million raise through SPP and Placement
Shareholder approval sought for tranche 2 shares and new options
400:1 share consolidation subject to shareholder vote
Bell Potter appointed as lead manager with 6% commission
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE